Diagnosis and treatment of pericarditis

Heart

Volumn 101, Issue 14, 2015, Pages 1159-1168

  Imazio, Massimo ^a   Gaita, Fiorenzo ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; C REACTIVE PROTEIN; COLCHICINE; HUMAN IMMUNOGLOBULIN; IBUPROFEN; INDOMETACIN; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER; CARDIOVASCULAR AGENT;

ANAMNESIS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; ERYTHROCYTE COUNT; GENETIC PREDISPOSITION; HUMAN; IMAGE ANALYSIS; LEUKOCYTE COUNT; PERICARDIAL BIOPSY; PERICARDIAL DISEASE; PERICARDIAL EFFUSION; PERICARDIAL FRICTION RUB; PERICARDIECTOMY; PERICARDIOCENTESIS; PERICARDIOTOMY; PERICARDITIS; PR INTERVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEDIMENTATION RATE; ST SEGMENT ELEVATION; T WAVE AMPLITUDE; T WAVE INVERSION; THORAX PAIN; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; ADVERSE EFFECTS; BLOOD; CARDIOVASCULAR SYSTEM EXAMINATION; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; HEART CATHETERIZATION; HEART SURGERY; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

BIOMARKERS; CARDIAC CATHETERIZATION; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR AGENTS; DIAGNOSTIC IMAGING; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; ELECTROCARDIOGRAPHY; HUMANS; PATIENT SELECTION; PERICARDITIS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84934269151     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-306362     Document Type: Article

References (63)

1. Kabbani SS, LeWinter MM. Pericardial diseases. Curr Treat Options Cardiovasc Med 2002;4:487-95.
2. Spodick DH. Colchicine effectively and safely treats acute pericarditis and prevents and treats recurrent pericarditides. Heart 2012;98:1035-6.
3. Spodick DH. Risk prediction in pericarditis: who to keep in hospital? Heart 2008;94:398-9.
4. Lilly LS. Treatment of acute and recurrent idiopathic pericarditis. Circulation 2013;127:1723-6.
5. Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol 2012;27:308-17.
6. Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart 2011;97:1882-92.
7. Imazio M, Brucato A, Barbieri A, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation 2013;128:42-9.
8. Imazio M, Cooper LT. Management of myopericarditis. Expert Rev Cardiovasc Ther 2013;11:193-201.
9. Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Relapsing pericarditis. Heart 2004;90:1364-8.
10. Imazio M, Brucato A, Cemin R, et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med 2013;369:1522-8.
11. Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation 2010;121:916-28.
12. Hoit BD. Management of effusive and constrictive pericardial heart disease. Circulation 2002;105:2939-42.
13. Sagristà-Sauleda J, Angel J, Sánchez A, et al. Effusive-constrictive pericarditis. N Engl J Med 2004;350:469-75.
14. Imazio M, Cecchi E, Demichelis B, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart 2008;94:498-501.
15. Syed FF, Ntsekhe M, Gumedze F, et al. Myopericarditis in tuberculous pericardial effusion: prevalence, predictors and outcome. Heart 2014;100:135-9.
16. Ntsekhe M, Mayosi BM. Tuberculous pericarditis with and without HIV. Heart Fail Rev 2013;18:367-73.
17. Permanyer-Miralda G. Acute pericardial disease: approach to the aetiologic diagnosis. Heart 2004;90:252-4.
18. Snyder MJ, Bepko J, White M. Acute pericarditis: diagnosis and management. Am Fam Physician 2014;89:553-60.
19. Imazio M. Clinical presentation and diagnostic evaluation of acute pericarditis. In: Post TW. ed. UpToDate. Waltham, MA (accessed 30 Jul 2014).
20. Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol 2004;43:1042-6.
21. Imazio M, Spodick DH, Brucato A, et al. Diagnostic issues in the clinical management of pericarditis. Int J Clin Pract 2010;64:1384-92.
22. Rossello X, Wiegerinck RF, Alguersuari J, et al. New electrocardiographic criteria to differentiate acute pericarditis and myocardial infarction. Am J Med 2014;127:233-9.
23. Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 2013;26:965-1012.
24. Imazio M, Brucato A, Spodick DH, et al. Prognosis of myopericarditis as determined from previously published reports. J Cardiovasc Med (Hagerstown) 2014;15:835-9.
25. Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation 2011;123:1092-7.
26. Rigante D, Cantarini L, Imazio M, et al. Autoinflammatory diseases and cardiovascular manifestations. Ann Med 2011;43:341-6.
27. Cantarini L, Rigante D, Merlini G, et al. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up. Semin Arthritis Rheum 2014;43:818-23.
28. Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation 2007;115:2739-44.
29. Imazio M, Brucato A, Derosa FG, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown) 2009;10:217-30.
30. Imazio M, Trinchero R. Triage and management of acute pericarditis. Int J Cardiol 2007;118:286-94.
31. Abu Fanne R, Banai S, Chorin U, et al. Diagnostic yield of extensive infectious panel testing in acute pericarditis. Cardiology 2011;119:134-9.
32. Lazaros G, Vlachopoulos C, Stefanadis C. Extensive infectious panel testing for acute pericarditis: a ghost hunt? Cardiology 2011;119:131-3.
33. Sagristá Sauleda J, Almenar Bonet L, Angel Ferrer J, et al. The clinical practice guidelines of the Sociedad Española de Cardiología on pericardial pathology. Rev Esp Cardiol 2000;53:394-412.
34. Montera MW, Mesquita ET, Colafranceschi AS, et al. Sociedade Brasileira de Cardiologia. I Brazilian guidelines on myocarditis and pericarditis. Arq Bras Cardiol 2013;100:1-36.
35. Maisch B, Seferović PM, Ristić AD, et al. Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004;25:587-610.
36. Yared K, Baggish AL, Picard MH, et al. Multimodality imaging of pericardial diseases. JACC Cardiovasc Imaging 2010;3:650-60.
37. Verhaert D, Gabriel RS, Johnston D, et al. The role of multimodality imaging in the management of pericardial disease. Circ Cardiovasc Imaging 2010;3:333-43.
38. Horneffer PJ, Miller RH, Pearson TA, et al. The effective treatment of postpericardiotomy syndrome after cardiac operations. A randomized placebo-controlled trial. J Thorac Cardiovasc Surg 1990;100:292-6.
39. Imazio M, Adler Y. Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis. Heart Fail Rev 2013;18:355-60.
40. Imazio M. Evaluation and management of pericarditis. Expert Rev Cardiovasc Ther 2011;9:1221-33.
41. Lotrionte M, Biondi-Zoccai G, Imazio M, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J 2010;160:662-70.
42. Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis. J Cardiovasc Med (Hagerstown) 2010;11:712-22.
43. Imazio M, Brucato A, Trinchero R, et al. Individualized therapy for pericarditis. Expert Rev Cardiovasc Ther 2009;7:965-75.
44. Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 2008;118:667-71.
45. Imazio M, Brucato A, Cemin R, et al., CORP (COlchicine for Recurrent Pericarditis) Investigators. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 2011;155:409-14.
46. Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet 2014;383:2232-7.
47. Imazio M, Brucato A, Belli R, et al. Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014 - systematic review and meta-analysis. J Cardiovasc Med (Hagerstown) 2014;15:840-6.
48. Imazio M, Brucato A, Trinchero R, et al. Colchicine for pericarditis: hype or hope? Eur Heart J 2009;30:532-9.
49. Vianello F, Cinetto F, Cavraro M, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol 2011;147:477-8.
50. Moretti M, Buiatti A, Merlo M, et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol 2013;112:1493-8.
51. Finetti M, Insalaco A, Cantarini L, et al. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr 2014;164:1425-31.
52. Vassilopoulos D, Lazaros G, Tsioufis C, et al. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra). Int J Cardiol 2012;160:66-8.
53. Imazio M. Treatment of recurrent pericarditis. Rev Esp Cardiol (Engl Ed) 2014;67:345-8.
54. Seidenberg PH, Haynes J. Pericarditis: diagnosis, management, and return to play. Curr Sports Med Rep 2006;5:74-9.
55. Pelliccia A, Corrado D, Bjørnstad HH, et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil 2006;13:876-85.
56. Ristić AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2014;35:2279-84.
57. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J 2013;34:1186-97.
58. Dudzinski DM, Mak GS, Hung JW. Pericardial diseases. Curr Probl Cardiol 2012;37:75-118.
59. Cho YH, Schaff HV. Surgery for pericardial disease. Heart Fail Rev 2013;18:375-87.
60. Khandaker MH, Schaff HV, Greason KL, et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin Proc 2012;87:1062-70.
61. Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation 2011;124:1270-5.
62. Imazio M, Brucato A, Adler Y, et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am J Cardiol 2007;100:1026-8.
63. Brucato A, Brambilla G, Moreo A, et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol 2006;98:267-71.